PSMB9 and Miyoshi myopathy: This study aimed to delineate the clinical characteristics of newly diagnosed MM patients and investigate the influence of single nucleotide polymorphisms (SNPs) in PSMB6 and PSMB9 genes on the risk and response to BTZ-based chemotherapy, in comparison with the control group.